

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cysteine metabolic process (GO:0006534) | 6.00260716 |
| 2 | regulation of plasminogen activation (GO:0010755) | 5.66731321 |
| 3 | sulfur amino acid catabolic process (GO:0000098) | 5.45186464 |
| 4 | homocysteine metabolic process (GO:0050667) | 5.16146254 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 5.06112671 |
| 6 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.85612433 |
| 7 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.85612433 |
| 8 | purine nucleotide salvage (GO:0032261) | 4.75162341 |
| 9 | microtubule nucleation (GO:0007020) | 4.64246331 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.57080530 |
| 11 | platelet dense granule organization (GO:0060155) | 4.32966151 |
| 12 | white fat cell differentiation (GO:0050872) | 4.29489809 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.18372229 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10933483 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10933483 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.10933483 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10933483 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.10933483 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10933483 |
| 20 | negative regulation of Ras GTPase activity (GO:0034261) | 4.10224337 |
| 21 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.97929371 |
| 22 | adenosine metabolic process (GO:0046085) | 3.96464992 |
| 23 | neutrophil mediated immunity (GO:0002446) | 3.95010968 |
| 24 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.80305940 |
| 25 | leukotriene biosynthetic process (GO:0019370) | 3.77670717 |
| 26 | cellular extravasation (GO:0045123) | 3.75730416 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 3.71758076 |
| 28 | microglial cell activation (GO:0001774) | 3.71137364 |
| 29 | interferon-gamma production (GO:0032609) | 3.61836733 |
| 30 | negative regulation of interleukin-1 production (GO:0032692) | 3.58237243 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57121585 |
| 32 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.50530222 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44252253 |
| 34 | macrophage activation (GO:0042116) | 3.42050145 |
| 35 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.35880168 |
| 36 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.35846966 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.33253789 |
| 38 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.32352113 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 3.31966224 |
| 40 | myeloid leukocyte mediated immunity (GO:0002444) | 3.27736891 |
| 41 | cytidine deamination (GO:0009972) | 3.23752486 |
| 42 | cytidine metabolic process (GO:0046087) | 3.23752486 |
| 43 | cytidine catabolic process (GO:0006216) | 3.23752486 |
| 44 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.22363446 |
| 45 | response to lipoprotein particle (GO:0055094) | 3.21945020 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17862704 |
| 47 | energy homeostasis (GO:0097009) | 3.15568597 |
| 48 | muscle atrophy (GO:0014889) | 3.07297610 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.07062512 |
| 50 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.02825348 |
| 51 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.02495496 |
| 52 | growth hormone secretion (GO:0030252) | 2.99529560 |
| 53 | response to host immune response (GO:0052572) | 2.98184320 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98184320 |
| 55 | desmosome organization (GO:0002934) | 2.95494544 |
| 56 | detection of biotic stimulus (GO:0009595) | 2.94929261 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 2.94169985 |
| 58 | DNA deamination (GO:0045006) | 2.93815107 |
| 59 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93770941 |
| 60 | organic cation transport (GO:0015695) | 2.92648089 |
| 61 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.91685041 |
| 62 | regulation of tight junction assembly (GO:2000810) | 2.90876488 |
| 63 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.90745496 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 2.90142948 |
| 65 | negative regulation of catenin import into nucleus (GO:0035414) | 2.89576390 |
| 66 | leukotriene metabolic process (GO:0006691) | 2.88597210 |
| 67 | adaptation of signaling pathway (GO:0023058) | 2.85626668 |
| 68 | neutrophil activation (GO:0042119) | 2.79333700 |
| 69 | protein-chromophore linkage (GO:0018298) | 2.78050982 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77772493 |
| 71 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.77575315 |
| 72 | secretory granule organization (GO:0033363) | 2.77362631 |
| 73 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.75644744 |
| 74 | response to peptidoglycan (GO:0032494) | 2.74014990 |
| 75 | T cell differentiation involved in immune response (GO:0002292) | 2.72355261 |
| 76 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.72355261 |
| 77 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.72355261 |
| 78 | monocyte differentiation (GO:0030224) | 2.72143594 |
| 79 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70012398 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68410429 |
| 81 | acrosome assembly (GO:0001675) | 2.65803948 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64847856 |
| 83 | negative regulation of cell killing (GO:0031342) | 2.58156014 |
| 84 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.58156014 |
| 85 | negative regulation of acute inflammatory response (GO:0002674) | 2.57454060 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 2.56881661 |
| 87 | respiratory burst (GO:0045730) | 2.56659200 |
| 88 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.55104916 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 2.52892027 |
| 90 | protein targeting to vacuole (GO:0006623) | 2.52181688 |
| 91 | protein targeting to lysosome (GO:0006622) | 2.52181688 |
| 92 | establishment of protein localization to vacuole (GO:0072666) | 2.52181688 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 2.52071094 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 2.50701539 |
| 95 | galactose catabolic process (GO:0019388) | 2.50214779 |
| 96 | detection of other organism (GO:0098543) | 2.46078548 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45443854 |
| 98 | response to host (GO:0075136) | 2.45443854 |
| 99 | response to host defenses (GO:0052200) | 2.45443854 |
| 100 | G-protein coupled receptor internalization (GO:0002031) | 2.44371448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.45226320 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.43637460 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.14598793 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.65858801 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47141155 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94297848 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.89332383 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.82494028 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79835858 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53515199 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36906446 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29864855 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.27550218 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17337274 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09369805 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06976792 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06393214 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97715145 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94205499 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86234582 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83417770 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83192514 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77484282 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73704527 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.73597393 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68705425 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65467482 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58611876 |
| 29 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.52314919 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.46474313 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41305330 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40831319 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.36728147 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36451949 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32876833 |
| 36 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32876833 |
| 37 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32876833 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32751207 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32330387 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30096937 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29453233 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29352407 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26589934 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25605010 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24102295 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22742929 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16667806 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14901409 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13079770 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08567855 |
| 51 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08500565 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07393864 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04213482 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04166084 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03861349 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03317210 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02436498 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02328622 |
| 59 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.00342297 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97652470 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97024764 |
| 62 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96939241 |
| 63 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.94779176 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94642154 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93802288 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93242466 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92511966 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91953082 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91022874 |
| 70 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90668459 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90007040 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90007040 |
| 73 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89565694 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 0.88749490 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86245251 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86141745 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86121494 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85749984 |
| 79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85497614 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85371131 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82407003 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82351456 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82317063 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81885023 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81331141 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80528266 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80510520 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80419155 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.80160449 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.80001680 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79934134 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79284973 |
| 93 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78465232 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.78378617 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77694810 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77286987 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77262458 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76944704 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.76769112 |
| 100 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76458238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.35396914 |
| 2 | MP0005360_urolithiasis | 3.25145538 |
| 3 | MP0003183_abnormal_peptide_metabolism | 2.98696392 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 2.84987683 |
| 5 | MP0003787_abnormal_imprinting | 2.79511976 |
| 6 | MP0008995_early_reproductive_senescence | 2.75619675 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.26666523 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.22238170 |
| 9 | MP0003195_calcinosis | 2.20975323 |
| 10 | MP0003045_fibrosis | 2.18818450 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.11355759 |
| 12 | MP0003436_decreased_susceptibility_to | 2.07343157 |
| 13 | MP0000371_diluted_coat_color | 2.04661674 |
| 14 | MP0001800_abnormal_humoral_immune | 1.95447564 |
| 15 | MP0001835_abnormal_antigen_presentation | 1.94058847 |
| 16 | MP0002095_abnormal_skin_pigmentation | 1.93796098 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 1.85063311 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 1.84839500 |
| 19 | MP0004510_myositis | 1.81876186 |
| 20 | MP0000013_abnormal_adipose_tissue | 1.78264236 |
| 21 | MP0003252_abnormal_bile_duct | 1.75364475 |
| 22 | MP0002419_abnormal_innate_immunity | 1.74630872 |
| 23 | MP0009764_decreased_sensitivity_to | 1.73695232 |
| 24 | MP0004130_abnormal_muscle_cell | 1.71629809 |
| 25 | MP0005671_abnormal_response_to | 1.68386440 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.67953680 |
| 27 | MP0002736_abnormal_nociception_after | 1.66891138 |
| 28 | MP0002723_abnormal_immune_serum | 1.62975737 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.62325809 |
| 30 | MP0005387_immune_system_phenotype | 1.59474347 |
| 31 | MP0001790_abnormal_immune_system | 1.59474347 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.58389794 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.55821410 |
| 34 | MP0001661_extended_life_span | 1.53328083 |
| 35 | MP0002006_tumorigenesis | 1.51626029 |
| 36 | MP0005025_abnormal_response_to | 1.48603348 |
| 37 | MP0004885_abnormal_endolymph | 1.46668450 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.45499948 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.45365914 |
| 40 | MP0005670_abnormal_white_adipose | 1.44817700 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.42940532 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.42054617 |
| 43 | MP0009785_altered_susceptibility_to | 1.41727536 |
| 44 | MP0001819_abnormal_immune_cell | 1.37092184 |
| 45 | MP0002822_catalepsy | 1.33378684 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.32277748 |
| 47 | MP0005164_abnormal_response_to | 1.31483007 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.27972445 |
| 49 | MP0003123_paternal_imprinting | 1.27130475 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.26640856 |
| 51 | MP0004381_abnormal_hair_follicle | 1.23741554 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.20864268 |
| 53 | MP0004947_skin_inflammation | 1.17767788 |
| 54 | MP0002398_abnormal_bone_marrow | 1.17307608 |
| 55 | MP0004142_abnormal_muscle_tone | 1.16922359 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.15892005 |
| 57 | MP0000604_amyloidosis | 1.13282889 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.11895571 |
| 59 | MP0000716_abnormal_immune_system | 1.11644447 |
| 60 | MP0008469_abnormal_protein_level | 1.09707753 |
| 61 | MP0002722_abnormal_immune_system | 1.09484792 |
| 62 | MP0005367_renal/urinary_system_phenotyp | 1.09277519 |
| 63 | MP0000516_abnormal_urinary_system | 1.09277519 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.07231021 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.06928256 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.06149127 |
| 67 | MP0001727_abnormal_embryo_implantation | 1.05746797 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.05574153 |
| 69 | MP0001944_abnormal_pancreas_morphology | 1.01686328 |
| 70 | MP0005332_abnormal_amino_acid | 1.00157162 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.98088756 |
| 72 | MP0005365_abnormal_bile_salt | 0.95169164 |
| 73 | MP0003646_muscle_fatigue | 0.94893960 |
| 74 | MP0000685_abnormal_immune_system | 0.93943235 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.93106392 |
| 76 | MP0005408_hypopigmentation | 0.92692539 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.92205996 |
| 78 | MP0009115_abnormal_fat_cell | 0.91000883 |
| 79 | MP0002971_abnormal_brown_adipose | 0.90238766 |
| 80 | MP0003786_premature_aging | 0.89945844 |
| 81 | MP0002928_abnormal_bile_duct | 0.88580725 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.87284125 |
| 83 | MP0001666_abnormal_nutrient_absorption | 0.87087912 |
| 84 | MP0004883_abnormal_blood_vessel | 0.86863484 |
| 85 | MP0002429_abnormal_blood_cell | 0.86751922 |
| 86 | MP0009763_increased_sensitivity_to | 0.85837716 |
| 87 | MP0001968_abnormal_touch/_nociception | 0.85483983 |
| 88 | MP0008872_abnormal_physiological_respon | 0.85374596 |
| 89 | MP0008260_abnormal_autophagy | 0.85008496 |
| 90 | MP0005220_abnormal_exocrine_pancreas | 0.84171884 |
| 91 | MP0002075_abnormal_coat/hair_pigmentati | 0.83557330 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83003032 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.81017182 |
| 94 | MP0002132_abnormal_respiratory_system | 0.80692003 |
| 95 | MP0000858_altered_metastatic_potential | 0.80338430 |
| 96 | MP0002405_respiratory_system_inflammati | 0.77991723 |
| 97 | MP0001851_eye_inflammation | 0.71606435 |
| 98 | MP0003866_abnormal_defecation | 0.70145995 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.70035601 |
| 100 | MP0001756_abnormal_urination | 0.69297521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 5.84424628 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 5.51014446 |
| 3 | Hyperalaninemia (HP:0003348) | 5.51014446 |
| 4 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 5.51014446 |
| 5 | Constricted visual fields (HP:0001133) | 4.68414799 |
| 6 | Esophageal varix (HP:0002040) | 4.40154541 |
| 7 | Anorexia (HP:0002039) | 4.16365398 |
| 8 | Congenital sensorineural hearing impairment (HP:0008527) | 4.16217830 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.90298883 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.89144786 |
| 11 | Pulmonary embolism (HP:0002204) | 3.74068011 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69775935 |
| 13 | Myocardial infarction (HP:0001658) | 3.68323950 |
| 14 | Myositis (HP:0100614) | 3.66039049 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.56231783 |
| 16 | Gingival bleeding (HP:0000225) | 3.55222043 |
| 17 | Action tremor (HP:0002345) | 3.43482098 |
| 18 | Conjunctival telangiectasia (HP:0000524) | 3.36764112 |
| 19 | Oligomenorrhea (HP:0000876) | 3.32513246 |
| 20 | Agitation (HP:0000713) | 3.25466236 |
| 21 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.24062382 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.23760584 |
| 23 | Arterial thrombosis (HP:0004420) | 3.20242241 |
| 24 | Fatigue (HP:0012378) | 3.04248898 |
| 25 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.89005200 |
| 26 | Thrombophlebitis (HP:0004418) | 2.85619058 |
| 27 | Optic neuritis (HP:0100653) | 2.76283526 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 2.76283526 |
| 29 | Homocystinuria (HP:0002156) | 2.73241463 |
| 30 | Abnormality of homocysteine metabolism (HP:0010919) | 2.73241463 |
| 31 | Peritonitis (HP:0002586) | 2.72249636 |
| 32 | Orchitis (HP:0100796) | 2.70550592 |
| 33 | Hemoptysis (HP:0002105) | 2.69811650 |
| 34 | Stomatitis (HP:0010280) | 2.65777231 |
| 35 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.53605654 |
| 36 | Urticaria (HP:0001025) | 2.51710564 |
| 37 | T lymphocytopenia (HP:0005403) | 2.44198960 |
| 38 | White forelock (HP:0002211) | 2.40927268 |
| 39 | Epistaxis (HP:0000421) | 2.40443515 |
| 40 | Postural tremor (HP:0002174) | 2.38194111 |
| 41 | Microcytic anemia (HP:0001935) | 2.35182869 |
| 42 | Pustule (HP:0200039) | 2.34399942 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.34278060 |
| 44 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31403108 |
| 45 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31403108 |
| 46 | Single umbilical artery (HP:0001195) | 2.31403108 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.31183400 |
| 48 | Poor speech (HP:0002465) | 2.30001135 |
| 49 | Joint hemorrhage (HP:0005261) | 2.29939580 |
| 50 | Genetic anticipation (HP:0003743) | 2.29718151 |
| 51 | Petechiae (HP:0000967) | 2.29414242 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.28345130 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.23883992 |
| 54 | Hypoalphalipoproteinemia (HP:0003233) | 2.23465996 |
| 55 | Cone-rod dystrophy (HP:0000548) | 2.17956992 |
| 56 | Recurrent skin infections (HP:0001581) | 2.15788074 |
| 57 | Pancreatitis (HP:0001733) | 2.14352433 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10620722 |
| 59 | Patchy hypopigmentation of hair (HP:0011365) | 2.08577977 |
| 60 | Granulocytopenia (HP:0001913) | 2.02968312 |
| 61 | Premature graying of hair (HP:0002216) | 2.01844263 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.00083523 |
| 63 | Eczematoid dermatitis (HP:0000976) | 1.99955805 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99824727 |
| 65 | Toxemia of pregnancy (HP:0100603) | 1.99486575 |
| 66 | Heterochromia iridis (HP:0001100) | 1.99118018 |
| 67 | Chronic otitis media (HP:0000389) | 1.98377110 |
| 68 | Leukocytosis (HP:0001974) | 1.98259159 |
| 69 | Pigmentary retinal degeneration (HP:0001146) | 1.96745052 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 1.95562925 |
| 71 | Purpura (HP:0000979) | 1.95316398 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93875577 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93875577 |
| 74 | Hemiplegia (HP:0002301) | 1.93631800 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93268719 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 1.92501438 |
| 77 | Chorioretinal atrophy (HP:0000533) | 1.90747645 |
| 78 | Recurrent fungal infections (HP:0002841) | 1.89597232 |
| 79 | Abnormality of eosinophils (HP:0001879) | 1.86204139 |
| 80 | Gangrene (HP:0100758) | 1.85911903 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 1.85587618 |
| 82 | Portal hypertension (HP:0001409) | 1.84654823 |
| 83 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.83536626 |
| 84 | Chronic hepatic failure (HP:0100626) | 1.83280716 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 1.81124710 |
| 86 | Clonus (HP:0002169) | 1.80770655 |
| 87 | Encephalitis (HP:0002383) | 1.78040714 |
| 88 | Meningitis (HP:0001287) | 1.77733126 |
| 89 | Maternal diabetes (HP:0009800) | 1.76203647 |
| 90 | Cavernous hemangioma (HP:0001048) | 1.75600619 |
| 91 | Vasculitis (HP:0002633) | 1.75517454 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.74551387 |
| 93 | Ketoacidosis (HP:0001993) | 1.72486161 |
| 94 | Hyperphosphatemia (HP:0002905) | 1.72191447 |
| 95 | Abnormality of the pericardium (HP:0001697) | 1.71883657 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70301920 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.69744004 |
| 98 | Palpebral edema (HP:0100540) | 1.69288750 |
| 99 | Biconcave vertebral bodies (HP:0004586) | 1.68357283 |
| 100 | Chronic diarrhea (HP:0002028) | 1.67398593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 4.16778883 |
| 2 | MAP2K3 | 3.86992332 |
| 3 | FGR | 3.03280089 |
| 4 | FRK | 2.99663679 |
| 5 | MAP4K2 | 2.88248323 |
| 6 | SGK2 | 2.87645800 |
| 7 | ACVR1B | 2.58014020 |
| 8 | SGK223 | 2.55779264 |
| 9 | SGK494 | 2.55779264 |
| 10 | PIK3CG | 2.44075825 |
| 11 | MAP3K11 | 2.38189881 |
| 12 | JAK3 | 2.38065103 |
| 13 | SGK3 | 2.17858395 |
| 14 | BLK | 2.10658293 |
| 15 | CAMKK2 | 1.68659723 |
| 16 | ERN1 | 1.58874415 |
| 17 | TXK | 1.57679017 |
| 18 | IRAK4 | 1.54688181 |
| 19 | YES1 | 1.54472804 |
| 20 | ITK | 1.53002130 |
| 21 | IKBKE | 1.50966309 |
| 22 | NTRK3 | 1.50808646 |
| 23 | PINK1 | 1.50015042 |
| 24 | TAOK3 | 1.45305986 |
| 25 | IRAK1 | 1.45077850 |
| 26 | CDK9 | 1.42059676 |
| 27 | BCKDK | 1.36703963 |
| 28 | MAP4K1 | 1.34312287 |
| 29 | MAP2K7 | 1.31874722 |
| 30 | NLK | 1.27958284 |
| 31 | WNK1 | 1.24997506 |
| 32 | TAOK1 | 1.23205536 |
| 33 | CAMK1D | 1.21969366 |
| 34 | RIPK4 | 1.19208202 |
| 35 | MAP3K2 | 1.18361806 |
| 36 | LRRK2 | 1.09997895 |
| 37 | TEC | 1.08945413 |
| 38 | CSK | 1.07613836 |
| 39 | MAP3K1 | 1.06250377 |
| 40 | JAK2 | 1.05532815 |
| 41 | SYK | 1.03915951 |
| 42 | ADRBK1 | 0.99991260 |
| 43 | PIM1 | 0.96792701 |
| 44 | SGK1 | 0.96567226 |
| 45 | MOS | 0.96106235 |
| 46 | DYRK1B | 0.95046586 |
| 47 | STK10 | 0.92127944 |
| 48 | CCNB1 | 0.90307245 |
| 49 | SCYL2 | 0.86334026 |
| 50 | NEK6 | 0.85880602 |
| 51 | IRAK2 | 0.80657257 |
| 52 | TNIK | 0.80144717 |
| 53 | TLK1 | 0.79440494 |
| 54 | TAOK2 | 0.78212735 |
| 55 | MAP3K14 | 0.76055599 |
| 56 | TRPM7 | 0.75995935 |
| 57 | NTRK2 | 0.74252919 |
| 58 | GRK7 | 0.73840855 |
| 59 | TYK2 | 0.73803112 |
| 60 | STK11 | 0.71538537 |
| 61 | HIPK2 | 0.71282651 |
| 62 | MAP3K6 | 0.70539511 |
| 63 | IKBKB | 0.70331849 |
| 64 | GRK6 | 0.69404202 |
| 65 | TNK2 | 0.69363837 |
| 66 | MAP3K5 | 0.68702904 |
| 67 | LMTK2 | 0.67533459 |
| 68 | PHKG2 | 0.67323362 |
| 69 | PHKG1 | 0.67323362 |
| 70 | AKT3 | 0.67311741 |
| 71 | CAMK1G | 0.65287462 |
| 72 | LYN | 0.61025858 |
| 73 | FGFR3 | 0.59459657 |
| 74 | RPS6KB2 | 0.55005552 |
| 75 | KDR | 0.54214861 |
| 76 | BTK | 0.53264068 |
| 77 | GRK5 | 0.53008117 |
| 78 | ZAP70 | 0.51878532 |
| 79 | MARK3 | 0.51513878 |
| 80 | LCK | 0.50421636 |
| 81 | KSR1 | 0.49300976 |
| 82 | HCK | 0.48061457 |
| 83 | BRD4 | 0.47438270 |
| 84 | DYRK3 | 0.45389273 |
| 85 | CAMK1 | 0.43584377 |
| 86 | WNK4 | 0.43582059 |
| 87 | TBK1 | 0.42752292 |
| 88 | MAP3K4 | 0.39793237 |
| 89 | PRKAA2 | 0.38946939 |
| 90 | PTK6 | 0.38433685 |
| 91 | MAPK7 | 0.38131266 |
| 92 | ERBB2 | 0.37970394 |
| 93 | CAMK4 | 0.37663279 |
| 94 | CSNK1A1 | 0.34964647 |
| 95 | CHUK | 0.33807051 |
| 96 | FES | 0.33227522 |
| 97 | EPHB1 | 0.31579550 |
| 98 | MAP2K4 | 0.31542960 |
| 99 | MAP2K1 | 0.30905113 |
| 100 | EPHA3 | 0.27531050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.77665625 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.27788838 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.00245451 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.88046171 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.55951853 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93803165 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85918458 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77811874 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.74417077 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.73406838 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.68037156 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62638254 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.58941550 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.49845607 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49088203 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48722517 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47953668 |
| 18 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46541947 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42492952 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41291155 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38060101 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32792562 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.22643234 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.22446989 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.22392967 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22386521 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.22375793 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22147997 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.21088623 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20396258 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19706558 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19185082 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15799344 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11463544 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10604550 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10457227 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04802673 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04724919 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04468974 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04371220 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03652609 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01983023 |
| 43 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96866913 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96438972 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 0.96330606 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95813208 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92094183 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88487343 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87545775 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85853088 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.83488802 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83485424 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82843957 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 0.80199814 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79471862 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79053610 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77085718 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75677511 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.74476385 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73798978 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73215910 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72913758 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70107117 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66859745 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63850550 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62227927 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62061058 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.61703105 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61426529 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59454303 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56260213 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56149242 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55537006 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55212840 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54387846 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.53824644 |
| 77 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52428132 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51915008 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51486534 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50834044 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49331473 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.48111339 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47704640 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46930415 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46869022 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46156892 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.45907801 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45597551 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45040095 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44822900 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44023399 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42807589 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.42630529 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42300321 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42187134 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41661548 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.40804139 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40218738 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.40097626 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39170928 |

